Advertisement

Index by author

May 01, 2022; Volume 101,Issue 5

  1. Kosaka, Takeo

    1. Nuclear Ceramide Is Associated with Ataxia Telangiectasia Mutated Activation in the Neocarzinostatin-Induced Apoptosis of Lymphoblastoid Cells
      Nuclear Ceramide Is Associated with Ataxia Telangiectasia Mutated Activation in the Neocarzinostatin-Induced Apoptosis of Lymphoblastoid Cells
      Jun Fujita, Makoto Taniguchi, Chieko Hashizume, Yoshibumi Ueda, Shota Sakai, Tadakazu Kondo, Mayumi Hashimoto-Nishimura, Kentaro Hanada, Takeo Kosaka and Toshiro Okazaki
      Molecular Pharmacology May 2022, 101 (5) 322-333; DOI: https://doi.org/10.1124/molpharm.121.000379

  2. Langa, Paulina

    1. Effects of Sarcomere Activators and Inhibitors Targeting Myosin Cross-Bridges on Ca<sup>2+</sup>-Activation of Mature and Immature Mouse Cardiac Myofilaments
      Effects of Sarcomere Activators and Inhibitors Targeting Myosin Cross-Bridges on Ca2+-Activation of Mature and Immature Mouse Cardiac Myofilaments
      Monika Halas, Paulina Langa, Chad M. Warren, Paul H. Goldspink, Beata M. Wolska and R. John Solaro
      Molecular Pharmacology May 2022, 101 (5) 286-299; DOI: https://doi.org/10.1124/molpharm.121.000420

  3. Lazarenko, Roman M.

    1. VU6036720: The First Potent and Selective In Vitro Inhibitor of Heteromeric Kir4.1/5.1 Inward Rectifier Potassium Channels
      Samantha J. McClenahan, Caitlin N. Kent, Sujay V. Kharade, Elena Isaeva, Jade C. Williams, Changho Han, Andrew Terker, Robert Gresham, Roman M. Lazarenko, Emily L. Days, Ian M. Romaine, Joshua A. Bauer, Olivier Boutaud, Gary A. Sulikowski, Raymond Harris, C. David Weaver, Alexander Staruschenko, Craig W. Lindsley and Jerod S. Denton
      Molecular Pharmacology May 2022, 101 (5) 357-370; DOI: https://doi.org/10.1124/molpharm.121.000464

  4. Lebowitz, Joseph J.

    1. Agonist-Specific Regulation of G Protein–Coupled Receptors after Chronic Opioid Treatment
      Sweta Adhikary, Omar Koita, Joseph J. Lebowitz, William T. Birdsong and John T. Williams
      Molecular Pharmacology May 2022, 101 (5) 300-308; DOI: https://doi.org/10.1124/molpharm.121.000453

  5. Lindsley, Craig W.

    1. VU6036720: The First Potent and Selective In Vitro Inhibitor of Heteromeric Kir4.1/5.1 Inward Rectifier Potassium Channels
      Samantha J. McClenahan, Caitlin N. Kent, Sujay V. Kharade, Elena Isaeva, Jade C. Williams, Changho Han, Andrew Terker, Robert Gresham, Roman M. Lazarenko, Emily L. Days, Ian M. Romaine, Joshua A. Bauer, Olivier Boutaud, Gary A. Sulikowski, Raymond Harris, C. David Weaver, Alexander Staruschenko, Craig W. Lindsley and Jerod S. Denton
      Molecular Pharmacology May 2022, 101 (5) 357-370; DOI: https://doi.org/10.1124/molpharm.121.000464

  6. Lott, Joshua

    1. The Synthetic Cannabinoid WIN55,212-2 Can Disrupt the Golgi Apparatus Independent of Cannabinoid Receptor-1
      Joshua Lott, Emily M. Jutkiewicz and Manojkumar A. Puthenveedu
      Molecular Pharmacology May 2022, 101 (5) 371-380; DOI: https://doi.org/10.1124/molpharm.121.000377

  7. Mcclenahan, Samantha J.

    1. VU6036720: The First Potent and Selective In Vitro Inhibitor of Heteromeric Kir4.1/5.1 Inward Rectifier Potassium Channels
      Samantha J. McClenahan, Caitlin N. Kent, Sujay V. Kharade, Elena Isaeva, Jade C. Williams, Changho Han, Andrew Terker, Robert Gresham, Roman M. Lazarenko, Emily L. Days, Ian M. Romaine, Joshua A. Bauer, Olivier Boutaud, Gary A. Sulikowski, Raymond Harris, C. David Weaver, Alexander Staruschenko, Craig W. Lindsley and Jerod S. Denton
      Molecular Pharmacology May 2022, 101 (5) 357-370; DOI: https://doi.org/10.1124/molpharm.121.000464

  8. Okazaki, Toshiro

    1. Nuclear Ceramide Is Associated with Ataxia Telangiectasia Mutated Activation in the Neocarzinostatin-Induced Apoptosis of Lymphoblastoid Cells
      Nuclear Ceramide Is Associated with Ataxia Telangiectasia Mutated Activation in the Neocarzinostatin-Induced Apoptosis of Lymphoblastoid Cells
      Jun Fujita, Makoto Taniguchi, Chieko Hashizume, Yoshibumi Ueda, Shota Sakai, Tadakazu Kondo, Mayumi Hashimoto-Nishimura, Kentaro Hanada, Takeo Kosaka and Toshiro Okazaki
      Molecular Pharmacology May 2022, 101 (5) 322-333; DOI: https://doi.org/10.1124/molpharm.121.000379

  9. Puthenveedu, Manojkumar A.

    1. The Synthetic Cannabinoid WIN55,212-2 Can Disrupt the Golgi Apparatus Independent of Cannabinoid Receptor-1
      Joshua Lott, Emily M. Jutkiewicz and Manojkumar A. Puthenveedu
      Molecular Pharmacology May 2022, 101 (5) 371-380; DOI: https://doi.org/10.1124/molpharm.121.000377

  10. Romaine, Ian M.

    1. VU6036720: The First Potent and Selective In Vitro Inhibitor of Heteromeric Kir4.1/5.1 Inward Rectifier Potassium Channels
      Samantha J. McClenahan, Caitlin N. Kent, Sujay V. Kharade, Elena Isaeva, Jade C. Williams, Changho Han, Andrew Terker, Robert Gresham, Roman M. Lazarenko, Emily L. Days, Ian M. Romaine, Joshua A. Bauer, Olivier Boutaud, Gary A. Sulikowski, Raymond Harris, C. David Weaver, Alexander Staruschenko, Craig W. Lindsley and Jerod S. Denton
      Molecular Pharmacology May 2022, 101 (5) 357-370; DOI: https://doi.org/10.1124/molpharm.121.000464
« Previous (Pages : 1 2 3 4 5 6 ... 6) Next »
Back to top

In this issue

Advertisement